Jones RJ - Search Results

1

Philadelphia chromosome-negative engraftment after autologous transplantation with granulocyte-macrophage colony-stimulating factor for chronic myeloid leukemia.

Gladstone DE, Bedi A, Miller CB, Noga SJ, Griffin CA, Piantadosi S, Cagnoni PJ, Brodsky RA, Smith BD, Douglas TT, Shpall EJ, Jones RJ. Gladstone DE, et al. Among authors: jones rj. Biol Blood Marrow Transplant. 1999;5(6):394-9. doi: 10.1016/s1083-8791(99)70016-9. Biol Blood Marrow Transplant. 1999. PMID: 10595817 Free article. Clinical Trial.

2

Impaired erythropoietin response to anemia after bone marrow transplantation.

Miller CB, Jones RJ, Zahurak ML, Piantadosi S, Burns WH, Santos GW, Spivak JL. Miller CB, et al. Among authors: jones rj. Blood. 1992 Nov 15;80(10):2677-82. Blood. 1992. PMID: 1421381 Free article.

3

Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalation.

Yeager AM, Wagner JE Jr, Graham ML, Jones RJ, Santos GW, Grochow LB. Yeager AM, et al. Among authors: jones rj. Blood. 1992 Nov 1;80(9):2425-8. Blood. 1992. PMID: 1421415 Free article.

4

Autologous graft-versus-host disease: a novel approach for antitumor immunotherapy.

Hess AD, Jones RJ, Morris LE, Noga SJ, Vogelsang GB, Santos GW. Hess AD, et al. Among authors: jones rj. Hum Immunol. 1992 Jul;34(3):219-24. doi: 10.1016/0198-8859(92)90115-4. Hum Immunol. 1992. PMID: 1429045 Review.

5

Purging with 4-hydroperoxycyclophosphamide combinations.

Jones RJ, Miller CB, Rowley SD. Jones RJ, et al. Prog Clin Biol Res. 1992;377:1-9; discussion 10-1. Prog Clin Biol Res. 1992. PMID: 1438406 No abstract available.

6

Fluorescence in situ hybridization to determine engraftment status after murine bone marrow transplant.

Hawkins AL, Jones RJ, Zehnbauer BA, Zicha MS, Collector MJ, Sharkis SJ, Griffin CA. Hawkins AL, et al. Among authors: jones rj. Cancer Genet Cytogenet. 1992 Dec;64(2):145-8. doi: 10.1016/0165-4608(92)90345-9. Cancer Genet Cytogenet. 1992. PMID: 1486564

7

Autologous graft-versus-host disease: a new frontier in immunotherapy.

Hess AD, Jones RJ, Morris LE, Noga SJ, Yeager AM, Vogelsang GB, Santos GW. Hess AD, et al. Among authors: jones rj. Bone Marrow Transplant. 1992;10 Suppl 1:16-21. Bone Marrow Transplant. 1992. PMID: 1521086 Review. No abstract available.

8

Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.

Yeager AM, Vogelsang GB, Jones RJ, Farmer ER, Altomonte V, Hess AD, Santos GW. Yeager AM, et al. Among authors: jones rj. Blood. 1992 Jun 1;79(11):3031-5. Blood. 1992. PMID: 1586747 Free article.

9

Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemia.

Miller CB, Platanias LC, Mills SR, Zahurak ML, Ratain MJ, Ettinger DS, Jones RJ. Miller CB, et al. Among authors: jones rj. J Natl Cancer Inst. 1992 Jan 15;84(2):98-103. doi: 10.1093/jnci/84.2.98. J Natl Cancer Inst. 1992. PMID: 1735886 Clinical Trial.

10

Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation.

Miller CB, Zehnbauer BA, Piantadosi S, Rowley SD, Jones RJ. Miller CB, et al. Among authors: jones rj. Blood. 1991 Aug 15;78(4):1125-31. Blood. 1991. PMID: 1868244 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

759 results

Search Page

Filters